Inhalational Anesthetics


Agent

Blood–gas partition coefficient

Desflurane

0.42

Nitrous oxide

0.47

Sevoflurane

0.65

Isoflurane

1.46

Halothane

2.5




  • Cardiac output: The uptake of the anesthetic gas into the blood is determined by the amount of blood flowing through the lung. Increased cardiac output means presenting more pulmonary blood with a lower agent concentration needing to be saturated. Therefore, the increased uptake results in decreased alveolar concentration and consequently slowing the rise of FA/FI. In other words, the rate at which FA approaches FI is indirectly proportional to cardiac output in the absence of shunting.


  • Tissue solubility: Solubility of the agent within muscle, fat, and other tissues also plays a role in determining how rapidly FA approaches FI. Compared to the alveoli, these peripheral smaller components of the volume of distribution saturate more slowly, as such the concentration in the alveoli is almost always higher than that in the brain.






      Strategies to Increase the Rate of Rise of FA


      In order to increase the rate at which FA reaches FI, several components can be manipulated.



      • Increasing minute ventilation: By increasing minute ventilation, the amount of fresh gas entering the alveolus is increased replacing the lung volume which has had gas taken away by the pulmonary blood. Therefore, increasing minute ventilation increases FA.


      • Increasing the delivered concentration: This is similar to the idea of “over-pressurization.” Over-pressurization can simply be understood as the inhalational equivalent to an IV bolus. By initially administering a much higher concentration, the actual desired concentration can be more rapidly achieved. The volume of distribution of the agent is saturated quicker, and this phenomenon is known as the concentration effect.


      • Second gas effect: Another gas may be added to the inhaled mixture of gases. Concomitantly administering two anesthetic gases results in a faster rise in concentration of each. This is known as the second gas effect.


      • Avoiding ventilation perfusion (VQ) mismatch: VQ mismatch results in shunting of blood, which exposes alveolar blood to less anesthetic gas and, therefore, lower partial pressure on the brain and slower anesthetic onset. This effect is more profound with less soluble agents.



      Metabolism and Elimination


      Elimination of inhalational anesthetics is primarily accomplished by exhalation, though minimal amount of elimination occurs percutaneously. Least soluble agents, that is, those with the lower blood gas partition coefficients, will have the fastest decrease of FA. These agents readily diffuse from the pulmonary venous blood into the alveoli and exhaled. Once the concentration of the agent in the venous blood drops below that of peripheral tissues, the agent stored in these tissues diffuses back into the venous blood, slowing the decline in FA (Table 10.2). Inhalational anesthetics with higher blood tissue coefficients take longer to wash out. It is generally accepted that 80–90 % of the inhalational anesthetic concentration must be eliminated for emergence to occur.


      Table 10.2
      Gas–tissue partition coefficients of inhalational anesthetics




























































      Tissue

      Desflurane

      Nitrous oxide

      Sevoflurane

      Isoflurane

      Halothane

      Brain

      1.22

      1.07

      1.69

      1.57

      1.88

      Heart

      1.22

      1.02

      1.69

      1.57

      1.7

      Liver

      1.49
       
      2

      1.86

      2.29

      Kidney

      0.89
       
      1.2

      1

      1.25

      Muscle

      1.73

      1.15

      2.62

      2.57

      2.92

      Fat

      29

      2.39

      52

      50

      57

      Metabolism plays a smaller role in elimination, as inhalational agents are exhaled primarily via the lungs. Halothane, isoflurane, sevoflurane, and desflurane are metabolized in the liver to fluoride compounds, which can accumulate after prolonged exposure. But these fluoride levels have not been shown to cause postoperative renal dysfunction.



      Pharmacodynamics


      The exact mechanism of action of inhalational anesthetics is unknown. The most common understanding is that there are multiple sites of action, which may not be uniform for all inhalational agents. Inhalational anesthetics are presumed to act on voltage-gated ion channels in cell membranes, thereby altering permeability and impairment of neurotransmitter function (see Chap. 9).

      The minimum alveolar concentration (MAC) of inhalational anesthetics is defined as the concentration of gas necessary to prevent movement to surgical stimulus in 50 % of patients. The MACs of common gases are shown in Table 10.3. The MAC of nitrous oxide is 104 %. This above impossible percentage means that the MAC of nitrous oxide cannot be achieved (except in a hyperbaric chamber) and it is a weak anesthetic.


      Table 10.3
      MAC of inhalational anesthetics

























      Agent

      MAC

      Halothane

      0.75

      Isoflurane

      1.17

      Sevoflurane

      2.05

      Desflurane

      6.6

      Nitrous oxide

      104

      In order to achieve a level of anesthesia in which 95 % of patients do not move, it takes MAC + 25 % (1.25 MAC). In order for a patient to not recall but lose self-awareness (MAC Aware), it generally takes 0.4 to 0.5 MAC. This means for induction of anesthesia at least 0.4–0.5 MAC is needed. Emergence takes place at approximately 10–20 % MAC, which equates to 0.15–0.2 MAC, meaning that it takes more to induce anesthesia in a patient but lower levels to emerge. Yet another term is the minimum alveolar concentration which blunts the adrenergic response (MAC-BAR), which is usually 1.5 MAC. Therefore, a 1.25 MAC may stop patient movement in 95 % of patients, but it will not suppress the physical signs of pain (tachycardia, tachypnea, and hypertension).

      The MAC of anesthetics is additive. Since only one volatile anesthetic can be used at a time, adding nitrous oxide as an adjunct allows the practitioner to avoid the negative side effects associated with higher concentrations of the volatile anesthetic. For example, using nitrous oxide at 0.5 MAC (52 %) combined with desflurane at 0.5 MAC (3.3 %) would result in 1 MAC and achieve a state where 50 % of patients do not react to stimulation. MAC is affected by many physiological states and pharmacologic interactions (Table 10.4). Of important note is that MAC is variable with age. From birth to one year, it is generally accepted that MAC increases to a peak. From this point on there is a decline. MAC declines at a rate of 5 % for every decade of life over 40 years of age.


      Table 10.4
      Factors affecting MAC of inhalational anesthetics




















































      Factor increasing MAC

      Factors decreasing MAC

      Hyperthermia

      Hypothermia

      Hypernatremia

      Hyponatremia, hypercalcemia

      Chronic alcoholic abuse

      Acute alcoholic intoxication

      Monoamine oxidase inhibitors

      Chronic dextroamphetamine use

      Acute cocaine intoxication

      Chronic cocaine use

      Acute dextroamphetamine use

      Hypotension, metabolic acidosis

      Ephedrine

      Hypoxia, hypercarbia
       
      Anemia
       
      Pregnancy
       
      Local anesthetics
       
      Clonidine, dexmedetomidine
       
      Barbiturates, ketamine, propofol
       
      Benzodiazepines
       
      Opiates


      Systemic Effects of Inhalational Agents



      Neurologic Effects


      Cerebral metabolic rate and oxygen consumption (CMRO2) are depressed by all potent volatile inhalational anesthetics. These changes parallel the slowing in the electroencephalogram (EEG). For all volatile anesthetics, except for halothane, once an isoelectric EEG is achieved, it is assumed that the CMRO2 has reached its nadir. Halothane concentrations above those that achieve an isoelectric EEG are usually toxic. Clinically, isoflurane causes the greatest decrease in CMRO2 and causes an isoelectric EEG at 2 MAC (lower concentration), compared to desflurane or sevoflurane, which take more than 2 MAC to cause an isoelectric EEG.

      Cerebral blood flow (CBF) is increased by volatile anesthetics, with halothane causing the greatest increase (avoid halothane for intracranial mass surgery). The increase in cerebral blood flow causes an increase in intracranial pressure (ICP). The rise in ICP follows the rise in CBF, meaning that halothane causes the greatest rise in ICP. Hyperventilation is commonly used before halothane (unlike other agents) preinduction or intubation in an attempt to blunt this effect. Isoflurane increases CBF and ICP above a 1 MAC concentration.

      Only gold members can continue reading. Log In or Register to continue

      Stay updated, free articles. Join our Telegram channel

    • Sep 18, 2016 | Posted by in ANESTHESIA | Comments Off on Inhalational Anesthetics

      Full access? Get Clinical Tree

      Get Clinical Tree app for offline access